Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Herr

Showing results (61-70 of 272) with videos related to

Pageof 28
Sort By:
Urologic Oncology|January 13, 2011
Selecting clinical research projects for the urologic oncologistH W Herr
Hematology/Oncology Clinics of North America|February 1, 1992
Intravesical therapyH W Herr
Surgical Forum|January 1, 1978
Nonspecific suppressor cells in peripheral blood of patients with urologic cancersH W Herr
BJU International|November 26, 1999
The natural history of a T1 bladder cancer: life-long tumour diathesisH W Herr
BJU International|July 31, 2003
Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality)H W Herr
Journal of the American Geriatrics Society|January 1, 1979
Preservation of sexual potency in prostatic cancer patients after 125I implantationH W Herr
Seminars in Urology|February 1, 1983
Carcinoma in situ of the bladderH W Herr
Seminars in Urologic Oncology|August 1, 1997
High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumorH W Herr
The Journal of Surgical Research|May 1, 1978
Immune reactivity of lymph nodes regional to prostatic cancerH W Herr
The Prostate|January 1, 1982
Effect of estrogen on the mixed lymphocyte reaction in normal individuals and prostatic cancer patientsH W Herr
Pageof 28

Showing results (61-70 of 272) with videos related to

Sort By:
Pageof 28
Urologic Oncology|January 13, 2011
Selecting clinical research projects for the urologic oncologistH W Herr
Hematology/Oncology Clinics of North America|February 1, 1992
Intravesical therapyH W Herr
Surgical Forum|January 1, 1978
Nonspecific suppressor cells in peripheral blood of patients with urologic cancersH W Herr
BJU International|November 26, 1999
The natural history of a T1 bladder cancer: life-long tumour diathesisH W Herr
BJU International|July 31, 2003
Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality)H W Herr
Journal of the American Geriatrics Society|January 1, 1979
Preservation of sexual potency in prostatic cancer patients after 125I implantationH W Herr
Seminars in Urology|February 1, 1983
Carcinoma in situ of the bladderH W Herr
Seminars in Urologic Oncology|August 1, 1997
High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumorH W Herr
The Journal of Surgical Research|May 1, 1978
Immune reactivity of lymph nodes regional to prostatic cancerH W Herr
The Prostate|January 1, 1982
Effect of estrogen on the mixed lymphocyte reaction in normal individuals and prostatic cancer patientsH W Herr
Pageof 28